SCM
SRPT icon

Sterling Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Sterling Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5K Buy
1,977
+865
+78% +$16.4K ﹤0.01% 1671
2026
Q1 		$24.2K Sell
1,112
-402
-27% -$7.78K ﹤0.01% 1945
2025
Q4 		$32.6K Buy
1,514
+435
+40% +$9.17K ﹤0.01% 1978
2025
Q3 		$20.8K Sell
1,079
-91
-8% -$1.62K ﹤0.01% 2117
2025
Q2 		$20K Buy
1,170
+865
+284% +$36.9K ﹤0.01% 1799
2025
Q1 		$19.5K Sell
305
-1,159
-79% -$122K ﹤0.01% 1664
2024
Q4 		$178K Sell
1,464
-190
-11% -$23.3K ﹤0.01% 1302
2024
Q3 		$207K Buy
+1,654
New +$229K ﹤0.01% 1258
2017
Q1 		– Sell
-9,205
Closed -$252K – 1007
2016
Q4 		$252K Buy
+9,205
New +$370K ﹤0.01% 869
2016
Q1 		– Sell
-5,760
Closed -$222K – 981
2015
Q4 		$222K Sell
5,760
-1,589
-22% -$51.5K ﹤0.01% 921
2015
Q3 		$236K Sell
7,349
-4,651
-39% -$158K ﹤0.01% 899
2015
Q2 		$365K Sell
12,000
-4,276
-26% -$87.4K ﹤0.01% 769
2015
Q1 		$216K Sell
16,276
-26,426
-62% -$352K ﹤0.01% 834
2014
Q4 		$618K Buy
42,702
+5,322
+14% +$90.1K 0.01% 736
2014
Q3 		$789K Buy
+37,380
New +$844K 0.01% 673
2014
Q2 		– Sell
-15,438
Closed -$371K – 932
2014
Q1 		$371K Buy
+15,438
New +$394K ﹤0.01% 823

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sterling Capital Management's SRPT Position: Q2 2026 in Review

Sterling Capital Management increased its Sarepta Therapeutics (SRPT) stake by 78% in Q2 2026, buying an estimated $16.4K and bringing the position to 1,977 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1671.

Sterling Capital Management first reported a position in SRPT in Q1 2014 and has held it in 16 quarters since. The position peaked at $789K in Q3 2014. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Sterling Capital Management held 1,977 shares of Sarepta Therapeutics worth $35.5K as of Q2 2026.
  • Sterling Capital Management bought 865 Sarepta Therapeutics shares in Q2 2026, an estimated $16.4K.
  • Sarepta Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1671 holding.
  • Sterling Capital Management first reported a position in Sarepta Therapeutics in Q1 2014 and has held it in 16 quarters since.
  • Sterling Capital Management's Sarepta Therapeutics position peaked at $789K in Q3 2014.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.